@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-ACES_SU-AS000139 a mbo:MassSpectrum ;
    dcterms:creator "ACESx, Jonathan W. Martin Group" ;
    dcterms:date "2022-08-15"^^xsd:date ;
    dcterms:identifier "MSBNK-ACES_SU-AS000139" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Stockholm University, ACESx, Jonathan W. Martin Group (C) 2022 under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "QExactive Orbitrap HF-X (Thermo Scientific)" ;
            mbo:collision_energy "Ramp 20%-70% (nominal)" ;
            mbo:column_name "Waters; Acquity UPLC BEH C18, 2.1 x 100 mm, 1.7 um, Waters" ;
            mbo:flow_gradient "98/2 at 4.2 min, 0/100 at 22 min, 0/100 at 25 min, 98/2 at 25.1 min, 98/2 at 30 min" ;
            mbo:flow_rate "0.45mL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-APCI-QFT" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "30000" ;
            mbo:retention_time "8.517400" ;
            mbo:solvent "A 1 mM ammonium fluoride in water",
                "B MeOH" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide",
                "Sulfamethoxazole" ;
            mbo:ch_compound_class "Drugs; Antiinfective Agents; Amines; Aniline Compounds; Sulfanilamides" ;
            mbo:ch_exact_mass 2.530521e+02 ;
            schema:inChI "InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)" ;
            schema:molecularFormula "C10H11N3O3S" ;
            schema:name "4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide",
                "Sulfamethoxazole" ;
            schema:smiles "O=S(=O)(NC1=NOC(=C1)C)C2=CC=C(N)C=C2" ] ;
    mbo:has_peak [ mbo:intensity 4.023325e+06 ;
            mbo:mz 6.50387e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 127 ],
        [ mbo:intensity 6.63723e+05 ;
            mbo:mz 1.460716e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 21 ],
        [ mbo:intensity 1.818261e+06 ;
            mbo:mz 1.470795e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 57 ],
        [ mbo:intensity 4.35481e+05 ;
            mbo:mz 1.480874e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 14 ],
        [ mbo:intensity 1.156864e+07 ;
            mbo:mz 1.560115e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 366 ],
        [ mbo:intensity 7.93148e+05 ;
            mbo:mz 1.600871e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 25 ],
        [ mbo:intensity 2.758819e+06 ;
            mbo:mz 1.880819e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 87 ],
        [ mbo:intensity 1.195901e+06 ;
            mbo:mz 1.900974e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 38 ],
        [ mbo:intensity 4.69522e+05 ;
            mbo:mz 1.940384e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 15 ],
        [ mbo:intensity 3.159731e+07 ;
            mbo:mz 2.540595e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.362235e+06 ;
            mbo:mz 6.804956e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 43 ],
        [ mbo:intensity 1.180568e+06 ;
            mbo:mz 8.004954e+01 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 37 ],
        [ mbo:intensity 9.996288e+06 ;
            mbo:mz 9.204976e+01 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 316 ],
        [ mbo:intensity 4.086513e+06 ;
            mbo:mz 9.305757e+01 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 129 ],
        [ mbo:intensity 3.42386e+05 ;
            mbo:mz 9.406506e+01 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 11 ],
        [ mbo:intensity 2.184462e+06 ;
            mbo:mz 9.905532e+01 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 69 ],
        [ mbo:intensity 1.17929e+07 ;
            mbo:mz 1.080446e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 373 ],
        [ mbo:intensity 1.279139e+06 ;
            mbo:mz 1.1006e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 40 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 3.149866e+02 ;
            mbo:precursor_mz_value "254.0596"^^xsd:float ] ;
    mbo:pk_num_peak 18 ;
    mbo:pk_splash "splash10-0zfr-6980000000-4f03feed7b34993c9abf" ;
    rdfs:comment "CONFIDENCE Standard Compound (Level 1)" ;
    skos:definition "Sulfamethoxazole; LC-APCI-QFT; MS2; CE: Ramp 20%-70% (nominal); R=30000; [M+H]+" .

